Safety and Treatment Outcome Study of PROCHYMAL® (Remestemcel-L) Intravenous Infusion in Subjects With Treatment-resistant Crohn's Disease
Last updated on July 2021Recruitment
- Recruitment Status
- No longer available
Summary
- Type
- Expanded Access
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT01510431
- Collaborators
- Not Provided
- Investigators
- Study Director: Mahboob Rahman, MD Mesoblast, Inc.
Get Well Soon